The Gist Healthcare Podcast

Ardent Health goes public... raising around $192 million dollars in its IPO. A summer COVID wave spreads across the US. And more states look to curb prescription drug costs with public affordability boards. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The FDA plans to launch a rare disease center to streamline its policies and methods for evaluating experimental drugs. Drugmaker Roche sees positive results from an early-stage trial of its obesity pill. And a new study finds that bone marrow transplant patients may not need a perfect donor match. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Steward Health Care confirms it is under federal investigation. A judge denies an extension for Georgia’s new Medicaid plan, the only in the nation with a work requirement. And new CDC data finds that Americans with disabilities are more likely to report long COVID symptoms. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The House Appropriations Committee is requesting that the FDA holds off on regulating laboratory developed tests. A recent report finds that private equity-backed providers account for less than 4 percent of the U.S. provider market by revenue. And a new study links semaglutide to lower risk for both dementia and nicotine use. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

In its first No Surprises audit, CMS finds some noncompliance with CVS-owned Aetna. State attorneys general warn of consumer impacts from the Change Healthcare cyberattack. And a report says about 7 percent of U.S. adults have had long COVID. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The Senate unanimously passes a bill that cracks down on drug patent practices. House GOP leaders demand regulatory reviews from federal agencies, including the Health and Human Services Department, following the Supreme Court’s Chevron decision. And a new study links alcohol to more than a half dozen cancers. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

CMS proposes a nearly 3 percent Medicare physician pay cut in 2025. The Office of the National Coordinator for Health Information Technology releases its proposed rule to improve data sharing. And a new observational study compares weight loss between adults on tirzepatide versus semaglutide. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Sanford Health and Marshfield Clinic Health System are exploring a combination. Medicare proposes a 2.6 percent pay increase for hospital outpatient departments and ambulatory surgical centers. And dozens of Medicare Advantage plans get higher star ratings after CMS recalculations. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

An interim FTC report scrutinizes pharmacy benefit managers. A proposed federal cybersecurity rule draws criticism from the healthcare industry. And dozens of health systems see their credit ratings drop. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

In two separate rulings, federal judges partially block both the FTC’s noncompete ban and a federal gender nondiscrimination rule. Massachusetts lawmakers target real estate investment trusts in a sweeping healthcare bill. And the FDA approves Eli Lilly’s early Alzheimer’s treatment. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.